Johnson & Johnson (JNJ)
265.88
-2.16
(-0.81%)
USD |
NYSE |
Aug 31, 16:00
266.10
+0.22
(+0.08%)
After-Hours: 17:23
Johnson & Johnson Total Assets (Quarterly) : 201.06B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 201.06B |
| March 31, 2026 | 200.89B |
| December 31, 2025 | 199.21B |
| September 30, 2025 | 192.82B |
| June 30, 2025 | 193.39B |
| March 31, 2025 | 193.67B |
| December 31, 2024 | 180.10B |
| September 30, 2024 | 178.29B |
| June 30, 2024 | 181.09B |
| March 31, 2024 | 171.97B |
| December 31, 2023 | 167.56B |
| September 30, 2023 | 166.06B |
| June 30, 2023 | 191.69B |
| March 31, 2023 | 195.97B |
| December 31, 2022 | 187.38B |
| September 30, 2022 | 175.12B |
| June 30, 2022 | 177.72B |
| March 31, 2022 | 178.36B |
| December 31, 2021 | 182.02B |
| September 30, 2021 | 179.23B |
| June 30, 2021 | 176.44B |
| March 31, 2021 | 172.56B |
| December 31, 2020 | 174.89B |
| September 30, 2020 | 170.69B |
| June 30, 2020 | 158.38B |
| Date | Value |
|---|---|
| March 31, 2020 | 155.02B |
| December 31, 2019 | 157.73B |
| September 30, 2019 | 155.52B |
| June 30, 2019 | 155.12B |
| March 31, 2019 | 150.03B |
| December 31, 2018 | 152.95B |
| September 30, 2018 | 155.70B |
| June 30, 2018 | 155.36B |
| March 31, 2018 | 156.62B |
| December 31, 2017 | 157.30B |
| September 30, 2017 | 155.66B |
| June 30, 2017 | 152.81B |
| March 31, 2017 | 144.92B |
| December 31, 2016 | 141.21B |
| September 30, 2016 | 140.37B |
| June 30, 2016 | 139.81B |
| March 31, 2016 | 136.23B |
| December 31, 2015 | 133.41B |
| September 30, 2015 | 133.27B |
| June 30, 2015 | 132.04B |
| March 31, 2015 | 128.59B |
| December 31, 2014 | 131.12B |
| September 30, 2014 | 132.10B |
| June 30, 2014 | 135.20B |
| March 31, 2014 | 133.33B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Pfizer Inc. | 201.13B |
| Bristol Myers Squibb Co. | 87.63B |
| Liquidia Corp. | 521.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 116.09B |
| Shareholders Equity (Quarterly) | 84.97B |
| Debt to Equity Ratio | 0.5771 |
| Current Ratio | 1.089 |
| Net Debt Paydown Yield | 0.11% |